CONCOMITANT FIBROMYALGIA AND DEPRESSION MIGHT BE A CAUSE OF DISCREPANCY BETWEEN BOOLEAN REMISSION AND DAS28 REMISSION IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Oner, S. Yilmaz [1 ]
Can, M. [1 ]
Atagunduz, P. [1 ]
Direskeneli, H. [1 ]
Inanc, N. [1 ]
机构：
[1] Marmara Univ, Sch Med, Istanbul, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：178 / 179
页数：2
相关论文
共 50 条
  • [31] Silent Progression in Patients with Rheumatoid Arthritis: Is DAS28 Remission an Insufficient Goal in RA? Results from the German Remission-PLUS Cohort
    Sewerin, Philipp
    Vordenbaeumen, Stefan
    Hoyer, Annika
    Brinks, Ralph
    Buchbender, Christian
    Schleich, Christoph
    Kamp, Sabine
    Antoch, Gerald
    Schneider, Matthias
    Ostendorf, Benedikt
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [32] Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort
    Philipp Sewerin
    Stefan Vordenbaeumen
    Annika Hoyer
    Ralph Brinks
    Christian Buchbender
    Falk Miese
    Christoph Schleich
    Sabine Klein
    Matthias Schneider
    Benedikt Ostendorf
    BMC Musculoskeletal Disorders, 18
  • [33] Comparative Results of DAS28 and Quality of Life in Patients with Rheumatoid Arthritis and Fibromyalgia
    Sivas, Filiz
    Aktekin, Lale Akbulut
    Eser, Filiz
    Yurdakul, Fatma Gul
    Oksuz, Ergun
    Ozoran, Kursat
    Bodur, Hatice
    TURKISH JOURNAL OF RHEUMATOLOGY, 2010, 25 (04) : 179 - 183
  • [34] REMAINING FOOT SYNOVITIS MAY PREDICT RELAPSE IN RHEUMATOID ARTHRITIS PATIENTS IN DAS28 REMISSION (DAS28-CRP<2.3)
    Hattori, S.
    Hagino, N.
    Yomono, K.
    Tsuzuki, S.
    Suzuki, S.
    Takenouchi, S.
    Yokochi, R.
    Matsui, T.
    Tohma, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1330 - 1330
  • [35] COMPARISON OF ACR/EULAR AND DAS28 REMISSION CRITERIA IN A COHORT OF TNF INHIBITOR TREATED RHEUMATOID ARTHRITIS PATIENTS
    Balogh, E.
    Dias, J. M.
    Mullan, R.
    Harty, L. C.
    Gallagher, P.
    Molloy, M.
    O'Flynn, E.
    O'Kelly, A.
    O'Neill, M.
    Moore, L.
    Murray, M.
    FitzGerald, O.
    Fearon, U.
    Veale, D. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 213 - 213
  • [36] Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis
    Jennie H. Best
    Yuting Kuang
    Yilin Jiang
    Rajpal Singh
    Andreas Karabis
    Jennifer Uyei
    Joseph Dang
    William G. Reiss
    Rheumatology and Therapy, 2021, 8 : 693 - 710
  • [37] Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis
    Best, Jennie H.
    Kuang, Yuting
    Jiang, Yilin
    Singh, Rajpal
    Karabis, Andreas
    Uyei, Jennifer
    Dang, Joseph
    Reiss, William G.
    RHEUMATOLOGY AND THERAPY, 2021, 8 (02) : 693 - 710
  • [38] Sex:: a major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis?
    Makinen, H.
    Hannonen, P.
    Sokka, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (07) : 1052 - 1053
  • [39] Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American college of Rheumatology-defined remission in rheumatoid arthritis
    Balsa, A
    Carmona, L
    González-Alvaro, I
    Belmonte, MA
    Tena, X
    Sanmartí, R
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (01) : 40 - 46
  • [40] M-FICOLIN, AN ACTIVATOR OF THE COMPLEMENT SYSTEM, PREDICTS DAS28 REMISSION IN EARLY DMARD NAIVE RHEUMATOID ARTHRITIS
    Ammitzboll, C. G.
    Jensenius, J. C.
    Ellingsen, T.
    Thiel, S.
    Horslev-Petersen, K.
    Hetland, M.
    Junker, P.
    Johansen, J.
    Ostergaard, M.
    Podenphant, J.
    Stengaard-Pedersen, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 131 - 131
12345